Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Schalekamp

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics of oral anticoagulant therapyTom Schalekamp, Anthonius de Boer
Pharmacy (Basel, Switzerland)|October 4, 2017
Implementation of Competency-Based Pharmacy Education (CBPE)Andries Koster, Tom Schalekamp, Irma Meijerman
Thrombosis and Haemostasis|January 10, 2009
Effect of oral antiplatelet agents on major bleeding in users of coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
Thrombosis and Haemostasis|January 10, 2009
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonMaarten Beinema, Jacobus R B J Brouwers, Tom Schalekamp, et al.
Archives of Internal Medicine|January 30, 2008
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
The Annals of Pharmacotherapy|November 1, 2007
Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmaciesHenk Buurma, Tom Schalekamp, Antoine C G Egberts, et al.
Drug Safety|April 28, 2005
Potential determinants of drug-drug interaction associated dispensing in community pharmaciesMatthijs L Becker, Marjon Kallewaard, Peter W J Caspers, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
Clinical and economic consequences of pharmacogenetic-guided dosing of warfarinTalitha I Verhoef, Tom Schalekamp, William K Redekop, et al.
Drugs & Aging|June 30, 2010
Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend studyMarjolein Geleedst-De Vooght, Anke-Hilse Maitland-van der Zee, Tom Schalekamp, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2006
Discrepancies between medication records of anticoagulation clinics and pharmacy recordsTom Schalekamp, Carolien Smit, Johanna H H van Geest-Daalderop, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics of oral anticoagulant therapyTom Schalekamp, Anthonius de Boer
Pharmacy (Basel, Switzerland)|October 4, 2017
Implementation of Competency-Based Pharmacy Education (CBPE)Andries Koster, Tom Schalekamp, Irma Meijerman
Thrombosis and Haemostasis|January 10, 2009
Effect of oral antiplatelet agents on major bleeding in users of coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
Thrombosis and Haemostasis|January 10, 2009
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonMaarten Beinema, Jacobus R B J Brouwers, Tom Schalekamp, et al.
Archives of Internal Medicine|January 30, 2008
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
The Annals of Pharmacotherapy|November 1, 2007
Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmaciesHenk Buurma, Tom Schalekamp, Antoine C G Egberts, et al.
Drug Safety|April 28, 2005
Potential determinants of drug-drug interaction associated dispensing in community pharmaciesMatthijs L Becker, Marjon Kallewaard, Peter W J Caspers, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
Clinical and economic consequences of pharmacogenetic-guided dosing of warfarinTalitha I Verhoef, Tom Schalekamp, William K Redekop, et al.
Drugs & Aging|June 30, 2010
Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend studyMarjolein Geleedst-De Vooght, Anke-Hilse Maitland-van der Zee, Tom Schalekamp, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2006
Discrepancies between medication records of anticoagulation clinics and pharmacy recordsTom Schalekamp, Carolien Smit, Johanna H H van Geest-Daalderop, et al.
Pageof 3